Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:1303-1307
Published online before print August 30, 2004, doi: 10.1161/01.CIR.0000140763.51679.D9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/10/1303    most recent
01.CIR.0000140763.51679.D9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corral, J.
Right arrow Articles by Vicente, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corral, J.
Right arrow Articles by Vicente, V.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUTAMIC ACID HYDROCHLORIDE
Related Collections
Right arrow Anticoagulant mechanisms
Right arrow Arterial thrombosis
Right arrow Deep vein thrombosis
Right arrow Coagulation
Right arrow Thrombosis risk factors
Right arrow Genetics of cardiovascular disease

(Circulation. 2004;110:1303-1307.)
© 2004 American Heart Association, Inc.


Original Articles

Homozygous Deficiency of Heparin Cofactor II

Relevance of P17 Glutamate Residue in Serpins, Relationship With Conformational Diseases, and Role in Thrombosis

Javier Corral, PhD; Justo Aznar, PhD; Rocio Gonzalez-Conejero, PhD; Piedad Villa, BSC; Antonia Miñano, T; Amparo Vayá, MD; Robin W. Carrell, PhD; James A. Huntington, PhD; Vicente Vicente, PhD

From the University of Murcia, Centro Regional de Hemodonación de Murcia, Murcia, Spain (J.C., R.G.-C., A.M., V.V.); Department of Clinical Pathology, La Fe University Hospital, Valencia, Spain (J.A., P.V., A.V.); and CIMR, University of Cambridge, Cambridge, UK (R.W.C., J.A.H.).

Correspondence to Dr Javier Corral, Centro Regional de Hemodonación, Ronda de Garay S/N, Murcia 30003, Spain. E-mail javier.corral{at}carm.es

Received December 18, 2003; de novo received February 19, 2004; revision received April 20, 2004; accepted April 21, 2004.

Background— Heparin cofactor II (HCII) is a hepatic serpin with significant antithrombin activity that has been implicated in coagulation, inflammation, atherosclerosis, and wound repair. Recent data obtained in mice lacking HCII suggest that this serpin might inhibit thrombosis in the arterial circulation. However, the clinical relevance and molecular mechanisms associated with deficiency of HCII in humans are unclear.

Methods and Results— We studied the first family with homozygous HCII deficiency, identifying a Glu428Lys mutation affecting a conserved glutamate at the hinge (P17) of the reactive loop. No carrier reported arterial thrombosis, and only 1 homozygous HCII-deficient patient developed severe deep venous thrombosis, but she also had a de novo Glu100Stop nonsense truncation in the antithrombin gene.

Conclusions— Our results confirm the key structural role of the P17 glutamate in serpins. The same mutation causes conformational instability and polymerization in 3 serpins: Drosophila necrotic, human {alpha}1-antitrypsin, and human HCII, which explains their plasma deficiency. In the family under study here, however, plasma HCII deficiency was not associated with a significant clinical phenotype.


Key Words: coagulation • genetics • proteins • risk factors • thrombosis




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H.-Y. Lin, C. Underhill, B. R. Gardill, Y. A. Muller, and G. L. Hammond
Residues in the Human Corticosteroid-binding Globulin Reactive Center Loop That Influence Steroid Binding before and after Elastase Cleavage
J. Biol. Chem., January 9, 2009; 284(2): 884 - 896.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. Gooptu and D. A. Lomas
Polymers and inflammation: disease mechanisms of the serpinopathies
J. Exp. Med., July 7, 2008; 205(7): 1529 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. A. Lomas
Parker B. Francis Lectureship. Antitrypsin Deficiency, the Serpinopathies, and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, August 1, 2006; 3(6): 499 - 501.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Corral, R. Gonzalez-Conejero, J. M. Soria, J. R. Gonzalez-Porras, E. Perez-Ceballos, R. Lecumberri, V. Roldan, J. C. Souto, A. Minano, D. Hernandez-Espinosa, et al.
A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis
Blood, July 1, 2006; 108(1): 177 - 183.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Mackman
Tissue-Specific Hemostasis in Mice
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2273 - 2281.
[Abstract] [Full Text] [PDF]